Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma

Clinical trial NCT01849263 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01849263
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Grade 3a Follicular Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Refractory Follicular Lymphoma

Start date: 2013-04-02
Primary completion: 2016-06-03
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.